Ornibel (Ethinylestradiol, Etonogestrel)

Ethinylestradiol, the active ingredient in Ornibel, is a combined hormonal contraceptive presented as a vaginal ring for vaginal use. It prevents pregnancy in women of reproductive age. GNH USA supplies Ornibel as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Ornibel as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Ornibel is a combined hormonal contraceptive that acts on the reproductive endocrine system to prevent pregnancy.

- Prevention of pregnancy: Provides reliable, reversible contraception for women seeking to avoid conception. - Menstrual cycle regulation: Helps achieve more predictable menstrual bleeding patterns. - Hormonal acne improvement: May reduce acne associated with hormonal fluctuations.

Adverse reactions may occur with any hormonal contraceptive and vary in frequency.

Common Side Effects: - Headache - Nausea - Breast tenderness - Vaginal irritation or discharge - Mood changes - Weight gain

Serious or Rare Side Effects: - Deep vein thrombosis or pulmonary embolism - Stroke or myocardial infarction - Severe allergic reaction (anaphylaxis) - Liver tumor or severe liver dysfunction

Before using Ornibel, patients should consider several safety factors.

- Smoking status: Avoid use if over 35 years old and a regular smoker. - Cardiovascular risk: Assess risk for hypertension, clotting disorders and stroke. - Liver health: Use only if the c  ...

Ornetic t t ...